基本信息
-
地索莫泰; L-异亮氨酰-L-蛋氨酰-L-alpha-天冬氨酰-L-谷氨酰胺酰-L-缬氨酰-L-脯氨酰-L-苯丙氨酰-L-丝氨酰-L-缬氨酸
-
181477-43-0
-
L-Isoleucyl-L-methionyl-L-alpha-aspartyl-L-glutaminyl-L-valyl-L-prolyl-L-phenylalanyl-L-seryl-L-valine
-
C47H74N10O14S
-
1035.21
-
L-Valine,L-isoleucyl-L-methionyl-L-a-aspartyl-L-glutaminyl-L-valyl-L-prolyl-L-phenylalanyl-L-seryl-
-
-
1.291g/cm3
-
L-Valine,N-[N-[N-[1-[N-[N2-[N-(N-L-isoleucyl-L-methionyl)-L-a-aspartyl]-L-glutaminyl]-L-valyl]-L-prolyl]-L-phenylalanyl]-L-seryl]-;10: PN: US20040191260 SEQID: 10 unclaimed sequence; 10: PN: US20060083735SEQID: 10 unclaimed sequence; 115: PN: WO03070752 SEQID: 1 claimed sequence;11: PN: WO2008039974 SEQID: 67 claimed protein; 13: PN: WO2009112792 SEQID: 15claimed protein; 146: PN: WO2004071457 PAGE: 38 claimed sequence; 16: PN:WO2005028505 SEQID: 16 claimed sequence; 170: PN: WO0178655 SEQID: 23 claimedsequence; 1812: PN: WO03040165 TABLE: 15 claimed protein; 18: PN: WO2008120202SEQID: 4 claimed sequence; 1: PN: CN101461942 PAGE: 2 claimed sequence; 1: PN:US20030003535 SEQID: 1 unclaimed sequence; 1: PN: WO0172768 SEQID: 1 unclaimedsequence; 1: PN: WO03086459 PAGE: 33 claimed sequence; 22: PN: WO2008058396SEQID: 21 unclaimed sequence; 22: PN: WO2009026547 SEQID: 36 unclaimed protein;27: PN: WO2008097817 SEQID: 27 unclaimed protein; 28: PN: US20080219947 SEQID:4 claimed sequence; 2: PN: FR2931163 SEQID: 2 unclaimed protein; 2: PN:WO2009089260 SEQID: 3 unclaimed protein; 2: PN: WO2009138489 SEQID: 2 unclaimedsequence; 324: PN: WO03062262 SEQID: 324 unclaimed sequence; 32: PN:WO2009125395 SEQID: 41 unclaimed protein; 33: PN: US20060246095 SEQID: 16claimed sequence; 33: PN: US20070166322 SEQID: 5 claimed sequence; 354: PN:US7420037 SEQID: 363 claimed protein; 36: PN: US20090075304 SEQID: 36 unclaimedsequence; 36: PN: US20090233318 SEQID: 36 unclaimed sequence; 36: PN:US20090304679 SEQID: 36 claimed protein; 36: PN: WO2009108372 SEQID: 36 claimedsequence; 3: PN: WO0194944 SEQID: 45 claimed protein; 3: PN: WO2009148915SEQID: 3 unclaimed sequence; 41: PN: WO2009033276 SEQID: 59 unclaimed protein;42: PN: WO02094981 SEQID: 42 claimed sequence; 44: PN: US20050053918 SEQID: 42claimed sequence; 44: PN: WO2008116937 TABLE: 3 unclaimed sequence; 49: PN:US20050215501 SEQID: 40 unclaimed sequence; 4: PN: US20090117153 SEQID: 4claimed sequence; 4: PN: WO03068201 SEQID: 2 claimed sequence;
-
831.1oC
-
-
1450.7oC at 760 mmHg
-
详细信息
杭州专肽生物(www.allpeptide.com)一直致力于、专注于修饰多肽的合成及研发,目前已经在很多方面取得了突破,并获得定制多肽行业的认可。 各类修饰让多肽的结构丰富起来,可以在多肽的N端、C端、活性侧链基团(羧基、氨基、羟基、酚羟基、巯基等)进行改造或形成各类环肽。同时多肽修饰让多肽的运用更加广泛起来,几乎所有的生物研究领域都有涉及到多肽,包括比较热门的肿瘤领域、生物材料领域,核磁共振领域等。
各类糖肽
各类荧光标记肽(Fam、FITC、TAMRRA、CY等)
含有DOTA、NOTA、DTPA等放射性螯合物前体多肽
众多羧基化合物和氨基化合物修饰的肽段
引入叠氮、炔基、烯基结构的肽段及点击化学运用
小分子、大分子PEG修饰
环肽(如酰胺、二硫键、硫酯、硫醚键、脲基成环)
引入叠氮、炔基、烯基结构的肽段及点击化学运用
同位素标记肽
环二肽
KLH和BSA蛋白载体多肽
R8S5订书肽
Dansyl和EDANS双标记肽
磷酸化肽磺酸化肽
甲基化肽
MAPs多聚抗原肽
醛肽
CMK、AMC、pNA